3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
8
Nasopharyngeal Carcinoma
5
Neoplasms
3
Colorectal Neoplasms
3
Uterine Cervical Neoplasms
2
Small Cell Lung Carcinoma
2
Rectal Neoplasms
2
Neoplasm Metastasis
2
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
Esophageal Neoplasms
2
Endometrial Neoplasms
2
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Sarcoma, Ewing
1
Recurrence
1
Rectal Diseases
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Neoplasms by Site
1
Meningeal Carcinomatosis
1
Lymphoma, T-Cell
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell
1
Lymphoma
1
Intestinal Neoplasms
1
Intestinal Diseases
1
Glioblastoma
1
Interventions
pembrolizumab
32
Cisplatin
23
Cetuximab
14
Carboplatin
13
Magnetic Resonance Spectroscopy
12
Specimen Handling
10
Radiotherapy, Intensity-Modulated
10
Paclitaxel
9
Nivolumab
9
Docetaxel
8
Platinum
7
1,2-diaminocyclohexaneplatinum II citrate
7
Radiotherapy
5
Biopsy
5
dostarlimab
4
atezolizumab
4
Immunoglobulin G
4
Disulfides
4
Bevacizumab
4
(225)Ac-DOTA-c(RGDyK)
4
cemiplimab
3
Taxes
3
Radiation
3
Fulvestrant
3
Fluorouracil
3
budigalimab
2
amivantamab
2
abemaciclib
2
Radiotherapy, Image-Guided
2
Pemetrexed
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Squamous Cell Carcinoma of Head and Neck
×
Drug Therapy
×
30 days
×
Clear all
No trials found.